...tumors showed evidence of regrowth following six weeks of radiation and chemotherapy. Northwest spokesperson Jane Searle...
...Phase III trial of the autologous dendritic cells treated ex vivo with glioblastoma tumor fragments. Searle...

...Imperial Innovations Group plc (LSE:IVO), London, U.K. Business: Finance, Other Departed: Susan Searle as CEO; she...

...Imperial Innovations Group plc (LSE:IVO) said Susan Searle departed as CEO. She is succeeded by Russ...

...and raising additional funds. LUM001 was discovered in the mid-1990s at G.D. Searle & Co. Pharmacia Corp. acquired Searle...
...is now a consultant to the firm. McKearn was formerly head of discovery research at Searle...

...The agent suppressed inflammatory substances known to damage joints, such as interleukin-1, metalloproteinases, and prostaglandins. G.D. Searle & Co....

...countries. Urispas has annual U.K. sales of £1 million (US$1.7 million) SHP said. SHP appointed G.D. Searle & Co....

...compound was discovered in the early 1990s in the lab of Dennis Riley at the G.D. Searle & Co....

...year on June 30, the company had £23.7 million ($35.4 million). According to CEO Susan Searle...
...in more mature companies. Previously, Imperial had made only seed or series A investments, but Searle...
...far and then exit them through an existing industry player that can take them further," Searle...

...of care to reduce and regress adenomatous colorectal polyps in patients with familial adenomatous polyposis. G.D. Searle & Co....

...what you've actually done," he said. The next landmark case was University of Rochester v. G.D. Searle & Co....
...a method of treating pain and inflammation by selectively inhibiting cyclooxygenase-2 (COX-2) but not COX-1. Searle...
...didn't have the chemistry capabilities to discover the compounds," Shuster said. Indeed, according to Shuster, Searle...